Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
The invention relates to a pharmaceutical composition suitable for injection as an aqueous suspension for sustained release of a bisphosphonate drug, the composition comprising: a sosoloid containing a salt of a bisphosphonate drug; and a salt of a pentavalent phosphorus oxoacid, the sosoloid having...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Polish |
Published |
27.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention relates to a pharmaceutical composition suitable for injection as an aqueous suspension for sustained release of a bisphosphonate drug, the composition comprising: a sosoloid containing a salt of a bisphosphonate drug; and a salt of a pentavalent phosphorus oxoacid, the sosoloid having a solubility in saline of less than 0.05% by weight as bisphosphonic acid for use as a medicament and for use in the prevention or treatment of a bone disease in a patient, in particular osteoporosis. |
---|---|
AbstractList | The invention relates to a pharmaceutical composition suitable for injection as an aqueous suspension for sustained release of a bisphosphonate drug, the composition comprising: a sosoloid containing a salt of a bisphosphonate drug; and a salt of a pentavalent phosphorus oxoacid, the sosoloid having a solubility in saline of less than 0.05% by weight as bisphosphonic acid for use as a medicament and for use in the prevention or treatment of a bone disease in a patient, in particular osteoporosis. |
Author | LUO, MARY ZIPING ZHANG, JACK YONGFENG DING, JIE FEI FEI, DINGYUAN XIE, KEVIN |
Author_xml | – fullname: XIE, KEVIN – fullname: LUO, MARY ZIPING – fullname: DING, JIE FEI – fullname: FEI, DINGYUAN – fullname: ZHANG, JACK YONGFENG |
BookMark | eNqNjb0OwjAQgzPAwN87hAdggBaJHYEYOjB0r47itpHSu9BL3p9G4gEYLFvyZ3ltFiyMlekq4d5GTKPVpJEc420neJDChoGmkVqk6FrytpUxiLrohOfMGXbzmD4JkjTvA1hzK519OQ2DZDFFbM2yI6_Y_Xxj9vdbfX0cEKSBhvmEEZtndTqXl7I81nVR_MN8AaTzQ30 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | Kompozycja farmaceutyczna o długotrwałym przedłużonym uwalnianiu, zawierającą wodną zawiesinę bisfosfonianu |
ExternalDocumentID | PL2548441TT3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_PL2548441TT33 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:57:20 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Polish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_PL2548441TT33 |
Notes | Application Number: PL20120186963T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150227&DB=EPODOC&CC=PL&NR=2548441T3 |
ParticipantIDs | epo_espacenet_PL2548441TT3 |
PublicationCentury | 2000 |
PublicationDate | 20150227 |
PublicationDateYYYYMMDD | 2015-02-27 |
PublicationDate_xml | – month: 02 year: 2015 text: 20150227 day: 27 |
PublicationDecade | 2010 |
PublicationYear | 2015 |
RelatedCompanies | Amphastar Pharmaceuticals Incorporation |
RelatedCompanies_xml | – name: Amphastar Pharmaceuticals Incorporation |
Score | 2.979215 |
Snippet | The invention relates to a pharmaceutical composition suitable for injection as an aqueous suspension for sustained release of a bisphosphonate drug, the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150227&DB=EPODOC&locale=&CC=PL&NR=2548441T3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjSt-Jc0o89FGHtxpBuK1Jlb6NpGzeQttiK_76XrNW96EOh9GhIDi6_u-R3dwB3toiYIRKu8wETGKAkkW4PHmydm6bFhKwIp5r2TWfm5IU9LYxFC9ZNLoyqE_qliiOiRcVo75Xar4vfQyxPcSvLe77GT_njOHQ8rY6O0bvp9y3NGzqjYO7NXc11ncDXZs8OxkE2In9Id2BXetGyzP7odSiTUoptRBkfwV6Ag2XVMbSK9w4cuE3jtQ7sT-v7bnytTa88AeHn2RuRGykpN0lPaUJkxxOEIVKstk-mieSJ12QsIrnomy4QJEIMwEBf_l9I3jpKc0H4uixWuXwynNEp3I5HoTvRccLLH-UsA79ZWkjpGbSzPEvPgVAjpUlMY7tHI8YTgX5crz9IWRobpmBCXED373G6_wkv4VAqWqV1W1fQrj4-02sE5orfKJV-A9oIlvY |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKc43nYrOWwTpW3E26WUPRVi7MbXbilTZ2-gtbiBtsRX_vidZp3vRh0JoSEgPnHz50u-cA3Bj8ZDpPInUqMc4EpQkVK3enaVGhmEyLjLCyaJ944kxemGPM33WgOU6FkbmCf2SyRHRo2L090ru18XvJZYrtZXlbbTEV_n9MLBdpWbHeLrRNFNx-_bAn7pTR3Ec2_eUybONPMhC5A_oFmybyAhFmv3Ba18EpRSbiDLchx0fJ8uqA2gU721oOevCa23YHdf_u7FZu155CNzLszciNlJSroKe0oSIiicIQ6RYbN5ME6ETr8VYRGjRV1UgSIgYgERfjC-Ebh17c06iZVkscvFkuKIjuB4OAmek4oLnP8aZ-9760wJKj6GZ5Vl6AoTqKU1iGltdGrIo4XiO62q9lKWxbnDG-Sl0_p6n81_nFbRGwdibew-TpzPYE0aXId7mOTSrj8_0AkG6ii6leb8BECaZ4Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Long+term+sustained+release+pharmaceutical+composition+containing+aqueous+suspension+of+bisphosphonate&rft.inventor=XIE%2C+KEVIN&rft.inventor=LUO%2C+MARY+ZIPING&rft.inventor=DING%2C+JIE+FEI&rft.inventor=FEI%2C+DINGYUAN&rft.inventor=ZHANG%2C+JACK+YONGFENG&rft.date=2015-02-27&rft.externalDBID=T3&rft.externalDocID=PL2548441TT3 |